Preclinical Research Unit, Drug Research Division, Sumitomo Pharma Co. Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.
Preclinical Research Unit, Drug Research Division, Sumitomo Pharma Co. Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.
Exp Eye Res. 2024 Apr;241:109847. doi: 10.1016/j.exer.2024.109847. Epub 2024 Feb 23.
Ivabradine, a hyperpolarization-activated cyclic nucleotide-gated (HCN) channel inhibitor, has been reported to induce photosensitivity-related visual disturbances such as phosphene in humans. Ivabradine-induced visual disturbances are caused by inhibition of HCN channels in the retina, and the mechanisms have been verified using HCN channel knockout mice and electroretinography (ERG). However, in rats, classical ERG using single flash light stimulus with standard analyses of waveform amplitude and latency has not revealed abnormal retinal function after administration of ivabradine. To verify whether retinal dysfunction after ivabradine administration was detectable in rats, we performed ERG using multistep flash light stimulation at the time when plasma concentration of ivabradine was high. Furthermore, the mechanism of the change in the waveform that appeared after the b-wave was investigated. Ivabradine and cilobradine, a selective HCN channel inhibitor, were administered subcutaneously to rats at 4-40 mg/kg as a single dose, and flash or long-duration ERG recordings at each light stimulus luminance were conducted 1.5 h after administration. Plasma and retinal concentrations of both compounds were measured immediately after the ERG recordings. In the flash ERG, prolongation of a- and/or b-wave latencies were detected at each light stimulus, and dose-dependent waveform changes after the b-wave were recorded at the specific light stimulus luminance for both compounds. These ERG changes increased in response to increasing plasma and retinal concentrations for both ivabradine and cilobradine. In the long-duration light stimulus ERG, a change in the waveform of the b-wave trough and attenuation of the c-wave were recorded, suggesting that the feedback control in the photoreceptor cells may be inhibited. This study revealed that the retinal dysfunction by HCN channel inhibitors in rats can be detected by multistep light stimulus ERG. Additionally, we identified that the inhibition of feedback current and the sustained responses in the photoreceptor cells cause the retinal dysfunction of HCN channel inhibitors in rats.
异搏定,一种超极化激活环核苷酸门控(HCN)通道抑制剂,已被报道可引起光敏相关的视觉障碍,如人体中的光幻视。异搏定引起的视觉障碍是由视网膜中 HCN 通道的抑制引起的,其机制已使用 HCN 通道敲除小鼠和视网膜电图(ERG)得到验证。然而,在大鼠中,使用单闪光光刺激的经典 ERG 并结合波形幅度和潜伏期的标准分析,并未显示异搏定给药后视网膜功能异常。为了验证大鼠给药后是否可检测到视网膜功能障碍,我们在异搏定血浆浓度较高时使用多步闪光光刺激进行 ERG。此外,还研究了 b 波后出现的波形变化的机制。将异搏定和西洛他唑,一种选择性 HCN 通道抑制剂,以 4-40mg/kg 的剂量皮下给药给大鼠,在给药后 1.5 小时进行每个光刺激亮度的闪光或长时程 ERG 记录。在 ERG 记录后立即测量两种化合物的血浆和视网膜浓度。在闪光 ERG 中,每个光刺激都检测到 a 和/或 b 波潜伏期延长,并且在两种化合物的特定光刺激亮度下记录到 b 波后的剂量依赖性波形变化。这些 ERG 变化随着两种化合物的血浆和视网膜浓度的增加而增加。在长时间光刺激 ERG 中,记录到 b 波波谷的波形变化和 c 波衰减,表明光感受器细胞中的反馈控制可能被抑制。这项研究表明,大鼠中 HCN 通道抑制剂引起的视网膜功能障碍可以通过多步光刺激 ERG 检测到。此外,我们确定了反馈电流的抑制和光感受器细胞中的持续反应导致了大鼠中 HCN 通道抑制剂的视网膜功能障碍。